Skip to main content
. 2024 May 23;81(1):233. doi: 10.1007/s00018-024-05269-1

Fig. 1.

Fig. 1

Contingency analysis of circulating tumour cell (CTC) numbers (A) in all HNSCC patients with and without recurrence. (B) in all head and neck squamous cell carcinoma (HNSCC) patients with and without death. (C) in all P16 positive oropharyngeal squamous cell carcinoma (OPSCC) patients with and without recurrence. (D) in P16 positive OPSCC patients with and without death. (E) in other HNSCC patients with and without recurrence. (F) in other HNSCC patients with and without death. Number of patients in each category are listed on the corresponding graph